Opioid-free anesthesia for minimally invasive abdominal surgery: a systematic review, meta-analysis, and trial sequential analysis
Authors:
- 5 November 2024
- journal article
- research article
- Published by Springer Nature in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 71 (11) , 1466-1485
Abstract
Purpose Opioid anesthesia is commonly employed in minimally invasive surgeries but is associated with adverse effects, including postoperative nausea and vomiting (PONV). Opioid-free anesthesia aims to mitigate these issues. We conducted a systematic review, meta-analysis, and trial sequential analysis (TSA) comparing opioid and opioid-free anesthesia in minimally invasive abdominal surgeries. Methods We searched the Cochrane Central Register of Controlled Trials, MEDLINE, and Embase for randomized controlled trials (RCTs) comparing these approaches. Our primary outcomes were adverse effects (PONV, bradycardia), while secondary outcomes were pain, opioid consumption, and postanesthesia care unit (PACU) length of stay (LOS). We performed a TSA to investigate the conclusiveness of the results. Results We included 26 RCTs encompassing 2,025 patients, with 1,009 (49%) in the opioid-free anesthesia group. Opioid-free anesthesia reduced PONV significantly (risk ratio, 0.55; 95% confidence interval [CI], 0.40 to 0.74; P < 0.001), but we found no significant differences in bradycardia rates. We found nonclinically relevant higher pain scores for opioid anesthesia (mean difference [MD], −0.9; 95% CI, −1.7 to −0.2; P = 0.01) and opioid consumption at 2 hr post surgery (MD, −5.4 mg oral morphine equivalents; 95% CI, −9.1 to −1.8; P = 0.004). We also noted a reduced time to first analgesia (MD, 88 min; 95% CI, 18 to 159; P = 0.01). We found no differences in PACU LOS. The TSA confirmed the sample size’s adequacy in showing PONV reduction with opioid-free anesthesia. Conclusion Opioid-free anesthesia showed a significant reduction in PONV and a decrease in opioid consumption during the first 2 hr postoperatively, suggesting it can be an alternative to opioid anesthesia in minimally invasive abdominal surgeries. Study registration PROSPERO (CRD42023492385); first submitted 18 December 2023.Keywords
This publication has 64 references indexed in Scilit:
- Dexmedetomidine is safe and effective for reducing intraprocedural pain in colorectal endoscopic submucosal dissectionDEN Open, 2023
- Impact of Opioid-Free Anesthesia on Analgesia and Recovery Following Bariatric Surgery: a Meta-Analysis of Randomized Controlled StudiesObesity Surgery, 2022
- Dexmedetomidine vs other sedatives in critically ill mechanically ventilated adults: a systematic review and meta-analysis of randomized trialsIntensive Care Medicine, 2022
- Perioperative adverse events attributed to α2-adrenoceptor agonists in patients not at risk of cardiovascular events: systematic review and meta-analysisBritish Journal of Anaesthesia, 2019
- A Multimodal Analgesic Protocol Reduces Opioid-Related Adverse Events and Improves Patient Outcomes in Laparoscopic Sleeve GastrectomyObesity Surgery, 2017
- Pilot study of a novel pain management strategy: evaluating the impact on patient outcomesSurgical Endoscopy, 2015
- Optimizing pain management to facilitate Enhanced Recovery After Surgery pathwaysCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2014
- Variations of the analgesia nociception index during general anaesthesia for laparoscopic abdominal surgeryJournal of Clinical Monitoring and Computing, 2012
- Esmolol versus ketamine-remifentanil combination for early postoperative analgesia after laparoscopic cholecystectomy: a randomized controlled trialCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2012
- Effect of morphine and incision length on bowel function after colectomyDiseases of the Colon & Rectum, 2000